Blood sampling for biomarkers analyses will be done at two times; the first as soon as possible after verification of CAD-diagnosis and the second 14 +/- 7 days after treatment onset. Measured biomarkers include: MMP9 and TIMP2. The biomarkers will be analysed with multiplex electrochemiluminescent immunosorbent assays .